Bmylong
6/20/22 BMYBristol-Myers Squibb Company ( NYSE:BMY )
Sector: (Pharmaceuticals: Major)
Market Capitalization: $157.061B
Current Price: $73.77
Breakout price: $76.75
Buy Zone (Top/Bottom Range): $73.20-$69.20
Price Target: $79.60-$80.20
Estimated Duration to Target: 92-97d
Contract of Interest: $BMY 9/16/22 80c
Trade price as of publish date: $0.98/contract
BMY Long Trade Idea
Enter Long
- Ideal price is $64-$66
Stop Loss
- $64.4
Profit Target
- $70-$71
ARK fund is dumping Bristol-Myers Squibb (BMY), should you?
Yet another solid company with solid financials who is currently trading at 65.6% below estimated fair values. Earnings are forecasted to grow 30.88% per year. This stock also pays out a reliable dividend of 2.96%. Caution as there has been significant insider selling over the past 3 months. I plan on buying this at open tomorrow and holding for a few weeks or until price target is reached.
For the six months ended 30 June 2021, Bristol-Myers Squibb Co revenues increased 9% to $22.78B. Net income totaled $3.08B vs. loss of $860M. Revenues reflect Prioritized Brands-Eliquis segment increase of 18% to$5.68B, Prioritized Brands-Revlimid segment increase of 6%to $6.15B, United States segment increase of 9% to $14.4B,Europe segment increase of 11% to $5.24B.
Long Bristol Myers for 2021 and beyond- Technical w/FundamentalBristol Myers is in a great position both fundamentally and technically. Time horizon is 1-2 years.
Technical:
Ascending Triangle with Price above the 30-day and 210-day simple moving averages. This could squeeze into the previous highs set in 2018 and 2016 (~$75).
We want to see the price continue to stay above these averages as well as the trend line connecting the recent higher lows.
Fundamental:
-Recent Celgene acquisition adds $18B in revenue and diversifies BMY's product portfolio. Before the acquisition, BMY's Top 3 Drugs made up almost 75% of its total revenue. After the acquisition this same ratio is only 43%, decreasing BMY's reliance on its top 3 drugs.
-Last three years the average P/E based on operating earnings for BMY has been 14.21, and at their current price they are trading at a 9.79, suggesting they may be currently undervalued.
-Dividend of $1.92 or 3.14% yield
-21.41% Adjusted Operating Earnings growth rate
-A+ S&P credit rating
Price Target = $100-110
BMY = Long Term Bullish Chart = Cup-N-Handle !!!!! 8/2/2020What up you crazy mother-flowers !!!!!!
Check out BMY on the freaking long term chart!!!
= Cup-N-Handle on the monthly chart and targets on the chart>
= Also the weekly chart you see a possible Rising 3 methods in the making above 20-moving-average but not confirmed yet>
= You will find Inverse head and shoulders on the Daily/Weekly chart witch is working on the move up from the right shoulder>
= I'm looking into a long term option trade on this one here>
Let me know what ya'll think....
BMY approaching resistance, potential drop!BMY is approaching our first resistance at 52.42(horizontal siwng high resistance, 61.8%, 100% fibonacci extension, 76.4%, 38.2% fibonacci retracement) where a strong drop might occur pushing price down to our major support at 48.35 (horizontal overlap support, 50% fibonacci retracement).
Stochastic (89,5,3) is also approaching resistance where we might see a corresponding drop in price.
BMY is approaching resistance, potential drop! BMY is approaching our first resistance at 52.42 (horizontal swing high resistance, 61.8% , 100% Fibonacci extension , 38.2%, 76.4% fibonacci retracement ) where a strong drop might occur below this level to our first support at 48.25 (horizontal overlap support, 50% fibonacci retracement ).
Stochastic (34,5,3) is also approaching resistance and seeing a bearish divergence where we might see a corresponding drop in price.
BMY approaching resistance, potetial drop! BMY is approaching our first resistance at 52.39(horizontal swing high resistance, 100% fiboancci extension, 76.4%, 38.2% Fibonacci retracement) where a strong drop might occur below this level pushing price down to our major support at 48.35 (horizontal overlap support, 50% Fibonacci retracement).
Stochastic (55,5,3) is also approaching resistance where we might see a corresponding drop in price.